29 April 2009 - Nanotherics and US-based Nanobiomagnetics have entered into a global cross-license agreement.
The companies are pioneering use of magnetically responsive nanoparticles for a range of life science research and human health applications, in the emerging field of nanomedicine, that include diagnostics and targeted therapeutic delivery systems.
